Effect of allopurinol on blood pressure: a systematic review and meta-analysis. - Test2 - elhamkhani - TriplyDB

Effect of allopurinol on blood pressure: a systematic review and meta-analysis.

Effect of allopurinol on blood pressure: a systematic review and meta-analysis.

http://www.wikidata.org/entity/Q31118679

about

Hyperuricemia, Cardiovascular Disease, and Hypertension Role of Uric Acid Metabolism-Related Inflammation in the Pathogenesis of Metabolic Syndrome Components Such as Atherosclerosis and Nonalcoholic Steatohepatitis Serum uric acid levels and multiple health outcomes: umbrella review of evidence from observational studies, randomised controlled trials, and Mendelian randomisation studies Uric acid: association with rate of renal function decline and time until start of dialysis in incident pre-dialysis patients.Impact of comorbidities on gout and hyperuricaemia: an update on prevalence and treatment options Cardiovascular co-morbidity in chronic kidney disease: Current knowledge and future research needs.The pathophysiology of hyperuricaemia and its possible relationship to cardiovascular disease, morbidity and mortality Allopurinol is an independent determinant of improved arterial stiffness in chronic kidney disease: a cross-sectional study.Renal oxidative stress induced by long-term hyperuricemia alters mitochondrial function and maintains systemic hypertension.Allopurinol Protects against Ischemia/Reperfusion-Induced Injury in Rat Urinary Bladders Hyperuricemia and coronary heart disease mortality: a meta-analysis of prospective cohort studies Pharmacotherapy for hyperuricemia in hypertensive patients.Hyperuricemia and the Prognosis of Hypertensive Patients: A Systematic Review and Meta-Analysis.Effect of Uric Acid Lowering on Renin-Angiotensin-System Activation and Ambulatory BP: A Randomized Controlled Trial.Effect of uric acid-lowering therapy on blood pressure: systematic review and meta-analysis.Xanthine oxidase inhibitors in ischaemic heart disease.Febuxostat for hyperuricemia in patients with advanced chronic kidney disease Allopurinol on hypertension: insufficient evidence to recommend.Weight Loss Mediated Reduction in Xanthine Oxidase Activity and Uric Acid Clearance in Adolescents with Severe Obesity.Xanthine oxidase inhibitors for prevention of cardiovascular events: a systematic review and meta-analysis of randomized controlled trials.Cardiac and renal protective effects of urate-lowering therapy.MR-PheWAS: exploring the causal effect of SUA level on multiple disease outcomes by using genetic instruments in UK Biobank.Is it Time to Find a Role for Uric Acid Levels in the Prevention and Management of Hypertension.Structure-activity relationships of fraxamoside as an unusual xanthine oxidase inhibitor.Effect of Xanthine Oxidase Inhibition on Arterial Stiffness in Patients With Chronic Heart Failure.Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2017 Urate crystal deposition, prevention and various diagnosis techniques of GOUT arthritis disease: a comprehensive review

P2860

Q26747880-448D22D3-5659-49B6-9807-F7AEDD2E6AA8 Q28354735-7711F6B9-B169-4B12-B8F3-464CCAD01218 Q33770852-71DB1C29-B9DB-48CB-A6C8-36433C73F5A6 Q33822935-C44A00CD-AAC6-4464-8D80-494CB8B623D4 Q33864537-5597FA01-03E5-4FCC-8705-932E3DC8677C Q34453236-D49BE73C-507A-491C-8428-5FB496FB8B8B Q34877729-61A59AEF-2645-4BE6-AA38-21A3DE7F26A2 Q35121532-4BAC7892-9349-48BE-B336-BCA87A71451A Q35414340-12FC1156-EFC5-40E2-991E-7D969FC5D7CF Q36145229-5D72A005-D0B1-4F3D-B242-9FDBEBB4AD70 Q36177428-C0F3CDB6-0D5D-4FC7-89C3-DFD335EB71B7 Q38838807-37BCF9FC-0300-43EF-A86F-86B824398B8E Q38849699-251EB680-A7CB-445F-BDD0-A9D91453E327 Q38892582-5A965A65-A223-4A05-881F-2B5CFEE44EC7 Q38968869-742B5C15-A14B-4F07-95D4-ABA7079412C7 Q39324330-81BE6B0A-7E16-4DB5-9624-6FDF946976DE Q42268534-EE035589-F91A-4743-874F-287008D45D99 Q44730629-78153DE9-04DD-4548-BD07-5686084626C1 Q47318326-E2ED6911-636F-42C0-9793-A57CE73454CD Q49584618-E24A7982-03FB-4803-923F-85302F21C0C4 Q49616077-7A68222A-D215-45BC-B33A-B5F537577763 Q50044432-05022AB7-D882-4245-9948-93AD00E0A946 Q51017941-84A8DB3C-11A2-4DA1-9457-6C90A7374FBB Q53568942-F2EB7EC0-9EEE-4951-8CFB-EFC432EC16B7 Q55176404-002EBB23-E1FF-4CC6-A214-31C3B5723951 Q58362346-816F13AF-84BD-49CE-A995-A8A46BB538B0 Q58580471-41B5AFCC-2059-4246-9AB1-F37D06424CE1

P2860

Effect of allopurinol on blood pressure: a systematic review and meta-analysis.

http://www.wikidata.org/entity/Q31118679

description

2012 nî lūn-bûn

@nan

2012 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Effect of allopurinol on blood pressure: a systematic review and meta-analysis.

@ast

Effect of allopurinol on blood pressure: a systematic review and meta-analysis.

@en

type

label

Effect of allopurinol on blood pressure: a systematic review and meta-analysis.

@ast

Effect of allopurinol on blood pressure: a systematic review and meta-analysis.

@en

prefLabel

Effect of allopurinol on blood pressure: a systematic review and meta-analysis.

@ast

Effect of allopurinol on blood pressure: a systematic review and meta-analysis.

@en

P1433

Q31118679-49E2A26C-F641-40BE-88DA-886245AC5D2E

P1476

Q31118679-FD864BF9-D216-47DF-9C30-D15177A5A113

P2093

Q31118679-3BFC0E6A-FE04-4C1F-A907-ADA99D30D193

Q31118679-847E17B8-D593-4913-8C0C-A866A26DCF55

Q31118679-F9D09F79-9351-439E-BB65-657C16D1EA65

P2860

Q31118679-14ED2E12-B221-4C91-9563-CA35E0B51C16

Q31118679-1DE1D2AA-16DA-4EE0-B5B6-0F6887D0C4FB

Q31118679-36FBA253-7420-4530-9A3F-6BBBE8D9E8D7

Q31118679-3EF115D0-1A96-407D-AD73-C5BFFF82DF5D

Q31118679-41E6B94A-914E-4615-8EBC-636257D82370

Q31118679-42B4CF77-357D-420D-A27C-C7E2774B2813

Q31118679-4FD9AEAA-0971-43B3-A520-B00C60A6FE35

Q31118679-5C50B1E8-BC7D-426B-B1BE-CE988B3E0026

Q31118679-5CD6CD25-2BD5-4BB6-AA52-6A1871560FC8

Q31118679-6B5E4204-24D4-402E-9CEB-57C22E0DF4EF

P304

Q31118679-9CBF585B-0FF1-4643-8BA0-CBB8EADB7497

P31

Q31118679-07FC54C1-6CCA-4283-B341-435970501523

Q31118679-f3bdd5f3-328f-436b-88cd-543e4db3aeb2

P356

Q31118679-F068AD4C-632F-4679-8463-256B7CA8E346

P433

Q31118679-311A3D5F-DB51-488D-9151-EE718DC9C2DF

P478

Q31118679-F6318C8B-7510-49FE-B0AA-6D46064E5C65

P577

Q31118679-DD47881D-A3CB-4365-9EBB-912FC8772311

P5875

Q31118679-304AB415-A71C-4E29-ADB4-ED66C58EF334

P698

Q31118679-D4EA80F3-0EF3-4F62-AEA7-BF076E2D264F

P356

J.1751-7176.2012.00701.X

P1433

Journal of Clinical Hypertension

P1476

Effect of allopurinol on blood pressure: a systematic review and meta-analysis.

@en

P2093

Franz H Messerli

http://www.w3.org/2001/XMLSchema#string

Nidhi Hans

http://www.w3.org/2001/XMLSchema#string

Vikram Agarwal

http://www.w3.org/2001/XMLSchema#string

P2860

Effect of allopurinol in chronic kidney disease progression and cardiovascular risk

Therapeutic effects of xanthine oxidase inhibitors: renaissance half a century after the discovery of allopurinol

Bias in meta-analysis detected by a simple, graphical test

Quantifying heterogeneity in a meta-analysis

Meta-analysis in clinical trials

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress

Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses

Acute adverse reactions attributed to allopurinol in hospitalised patients

Effect of high-dose allopurinol on exercise in patients with chronic stable angina: a randomised, placebo controlled crossover trial

P304

435-442

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1751-7176.2012.00701.X

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P577

2012-08-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

262043661

http://www.w3.org/2001/XMLSchema#string

P698

23730993

http://www.w3.org/2001/XMLSchema#string